IP Library Granted Patent US 10,844,410
Granted Patent B2
US 10,844,410 · App. 16/357,635 · Granted Nov 24, 2020

Mutant thioesterases

Inventors: Brian F. Pfleger (Madison, WI); Nestor Hernandez-Lozada (Madison, WI); Rung-Yi Lai (Changhua, TW)
Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
C12P7/6409C12N9/16C12N15/52C12N15/70C12Y301/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,410
App. No.
16/357,635
Granted
Nov 24, 2020
Kind
B2
Abstract

Mutant thioesterases having enhanced medium chain substrate activity, polynucleotides encoding and configured to express the mutant thioesterases in a transformed host cell, host cells transformed to contain the polynucleotides, and methods of using same.

Claims (45)

1. An unnatural, mutated protein comprising an amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4, wherein:

the amino acid sequence comprises:

a residue other than asparagine at a position corresponding to position 28 of SEQ ID NO:4; and

a residue other than isoleucine at a position corresponding to position 65 of SEQ ID NO:4;

the protein lacks an N-terminal portion having an amino acid sequence identical to positions 1-18 of SEQ ID NO:4; and

the protein exhibits thioesterase activity.

2. The protein of claim 1 , wherein the amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine, cysteine, threonine, tyrosine, or glutamine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine, alanine, leucine, phenylalanine, valine, proline, or glycine at the position corresponding to position 65 of SEQ ID NO:4.

3. The protein of claim 2 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

4. The protein of claim 1 , wherein the amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine at the position corresponding to position 65 of SEQ ID NO:4.

5. The protein of claim 4 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

6. The protein of claim 1 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

7. The protein of claim 1 , wherein the amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4 is an amino acid sequence at least about 85% identical to positions 19-317 of SEQ ID NO:4.

8. The protein of claim 7 , wherein the amino acid sequence at least about 85% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine, cysteine, threonine, tyrosine, or glutamine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine, alanine, leucine, phenylalanine, valine, proline, or glycine at the position corresponding to position 65 of SEQ ID NO:4.

9. The protein of claim 8 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

10. The protein of claim 7 , wherein the amino acid sequence at least about 85% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine at the position corresponding to position 65 of SEQ ID NO:4.

11. The protein of claim 10 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

12. The protein of claim 7 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

13. The protein of claim 1 , wherein the amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4 is an amino acid sequence at least about 90% identical to positions 19-317 of SEQ ID NO:4.

14. The protein of claim 13 , wherein the amino acid sequence at least about 90% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine, cysteine, threonine, tyrosine, or glutamine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine, alanine, leucine, phenylalanine, valine, proline, or glycine at the position corresponding to position 65 of SEQ ID NO:4.

15. The protein of claim 14 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

16. The protein of claim 13 , wherein the amino acid sequence at least about 90% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine at the position corresponding to position 65 of SEQ ID NO:4.

17. The protein of claim 16 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

18. The protein of claim 13 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

19. The protein of claim 1 , wherein the amino acid sequence at least about 80% identical to positions 19-317 of SEQ ID NO:4 is an amino acid sequence at least about 95% identical to positions 19-317 of SEQ ID NO:4.

20. The protein of claim 19 , wherein the amino acid sequence at least about 95% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine, cysteine, threonine, tyrosine, or glutamine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine, alanine, leucine, phenylalanine, valine, proline, or glycine at the position corresponding to position 65 of SEQ ID NO:4.

21. The protein of claim 20 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

22. The protein of claim 19 , wherein the amino acid sequence at least about 95% identical to positions 19-317 of SEQ ID NO:4 comprises:

a serine at the position corresponding to position 28 of SEQ ID NO:4; and

a methionine at the position corresponding to position 65 of SEQ ID NO:4.

23. The protein of claim 22 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

24. The protein of claim 19 , wherein the protein comprises, relative to a protein consisting of an amino acid sequence of SEQ ID NO:4, an N-terminal truncation of positions 1-18 of SEQ ID NO:4.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 2, 2019
From: UNIVERSITY OF WISCONSIN, MADISON
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 048773/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2019
From: PFLEGER, BRIAN; LAI, RUNG-TI; HERNANDEZ LOZADA, NESTOR
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 048712/0385 →
Continuity (2)
Provisional Application 62644954 · Mar 19, 2018
Related Publication 20190284588A1 · Sep 19, 2019
Cited By (1)
US 12,644,139